Dose-Response Study to Evaluate the Effect of BKR-017 on Insulin Resistance and Other Metabolic Parameters in Type 2 Diabetes Patients

NCT04673656 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DIETARY_SUPPLEMENT: BKR-017

Sponsor

BioKier Inc.